{
    "2020-09-14": [
        [
            {
                "time": "2020-11-09",
                "original_text": "Gilead Makes Its Biggest Buy Ever And Gets A 'Flagship' Cancer Drug",
                "features": {
                    "keywords": [
                        "Gilead",
                        "Biggest Buy",
                        "Cancer Drug"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2020-11-09",
                "original_text": "Eli Lilly, Incyte Combine Covid Drug With Gilead's, Post Positive Data",
                "features": {
                    "keywords": [
                        "Eli Lilly",
                        "Incyte",
                        "Covid Drug",
                        "Gilead",
                        "Positive Data"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-11-09",
                "original_text": "Gilead, Pfizer, Eli Lilly CEOs On COVID-19 Treatments, Vaccine Development",
                "features": {
                    "keywords": [
                        "Gilead",
                        "Pfizer",
                        "Eli Lilly",
                        "CEOs",
                        "COVID-19 Treatments",
                        "Vaccine Development"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2020-11-09",
                "original_text": "COVID SCIENCE-Flu outbreaks may be linked to COVID-19; arthritis drug benefit seen",
                "features": {
                    "keywords": [
                        "Flu Outbreaks",
                        "COVID-19",
                        "Arthritis Drug"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "medicine"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2020-11-09",
                "original_text": "Shares of Lilly and Incyte gain after late-stage study finds their arthritis drug can help reduce COVID-19 recovery time",
                "features": {
                    "keywords": [
                        "Lilly",
                        "Incyte",
                        "Arthritis Drug",
                        "COVID-19 Recovery Time"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-11-09",
                "original_text": "Regeneron's antibody drug added to UK Recovery trial of COVID treatments",
                "features": {
                    "keywords": [
                        "Regeneron",
                        "Antibody Drug",
                        "UK Recovery Trial",
                        "COVID Treatments"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotech",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2020-11-09",
                "original_text": "Baricitinib in Combination with Remdesivir Reduces Time to Recovery in Hospitalized Patients with COVID-19 in NIAID-Sponsored ACTT-2 Trial",
                "features": {
                    "keywords": [
                        "Baricitinib",
                        "Remdesivir",
                        "Time to Recovery",
                        "Hospitalized Patients",
                        "COVID-19",
                        "ACTT-2 Trial"
                    ],
                    "sentiment_score": 0.95,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-11-09",
                "original_text": "Innovent and Lilly Jointly Announce Results of Six Clinical Studies of TYVYT® (sintilimab injection) to be Presented at the European Society for Medical Oncology (ESMO) Virtual Congress 2020",
                "features": {
                    "keywords": [
                        "Innovent",
                        "Lilly",
                        "TYVYT®",
                        "Sintilimab Injection",
                        "ESMO Virtual Congress 2020"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals",
                        "oncology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            }
        ]
    ]
}